Filters
Results: 1 to 13 of 13
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States | 177 | 59 |
|
Fulgent Genetics United States | 82 | 30 |
|
Fulgent Genetics United States | 3 | 1 |
|
Fulgent Genetics United States | 70 | 26 |
|
Colorectal Cancer Comprehensive Panel Fulgent Genetics United States | 77 | 22 |
|
Gastric Cancer Comprehensive Panel Fulgent Genetics United States | 37 | 15 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 329 | 127 |
|
Pancreatic Cancer Comprehensive Panel Fulgent Genetics United States | 55 | 22 |
|
Nervous System / Brain Cancer Comprehensive Panel Fulgent Genetics United States | 133 | 27 |
|
Thyroid Cancer Comprehensive Panel Fulgent Genetics United States | 37 | 7 |
|
Fulgent Genetics United States | 62 | 18 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Fulgent Genetics United States | 4 | 1 |
|
Results: 1 to 13 of 13
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.